IFCI Q1 FY27 Results Analysis: Loan Book Stays Deeply Impaired, Profit Relies on One-Time Gain
IFCI Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 102.64 Cr (-34.00% YoY) and PAT growth of +17.07% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 11, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 102.64 Cr (-34.00% YoY) |
| PAT (Q1) | Rs. 8.64 Cr (+17.07% YoY) |
| EPS (Q1) | Rs. 0.03 (+0.00% YoY) |
| Market cap | Rs. 20,390.61 Cr |
| CMP | Rs. 75.71 |
Quarter Snapshot
IFCI's Q1FY27 results show a deeply impaired loan book (GNPA 95.68%), negative capital adequacy (-17.58% CRAR), and a standalone core loss before provisions. Profitability was entirely dependent on a one-time impairment reversal. The group consolidation plan offers a potential structural fix but remains in early stages with no timeline. Subsidiaries provide some earnings buffer, but the parent's financial position is critical.
Key Investment Insights
Key Positives
- Impairment reversal of Rs.48.30 Cr (standalone) swung the PBT from potential loss to profit of Rs.25.36 Cr
- Subsidiaries contributed Rs.24.88 Cr to owners' PAT, reversing a drag of Rs.8.14 Cr in Q4FY26
- Gross NPA ratio improved marginally from 95.79% in Mar-26 to 95.68% in Jun-26
- In-principle DFS approval received for group consolidation, which could address capital and structural issues
Risk Factors
- CRAR at −17.58% is critically below the RBI minimum of 15%, preventing new lending
- 95.68% of the loan book is classified as non-performing, with net NPA at 78.20%
- Standalone core business generates a pre-provision loss of Rs.22.94 Cr, entirely dependent on impairment reversals
- Standalone revenue declined 34% YoY due to fair value losses and lower fee income
- Other expenses doubled YoY and employee costs rose 25% YoY, increasing cost pressure
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.